C8 Part 2 Suppression of TNF alpha and IL-12 in Therapy

Date:: 2002-2009

Reference:: SA/KET/A/4/3/9a

Part of:: The Kennedy Trust for Rheumatology Research

Archives and manuscripts

Collection contents

The Kennedy Trust for Rheumatology ResearchSA/KET
- Drug DevelopmentSA/KET/A
  - PatentsSA/KET/A/4
    - Category C Owned by The Kennedy Institute Tied to Licensing Agreement With CentocorSA/KET/A/4/3
      - C8 Part 2 Suppression of TNF alpha and IL-12 in TherapySA/KET/A/4/3/9a

About this work

Description

See SA/KET/A/4/3/9 for item description.

Publication/Creation

2002-2009

Physical description

1 file (in 3 parts)

Language note

Greek

Terms of use

This item is held in offsite storage and requires a longer time for delivery.

Languages

Where to find it

Location Status Access
Closed stores

Permanent link

Page URL